Tuesday, 12 April 2016

Dr Reddys Laboratories buyback offer commences on April 18

Dr Reddys Laboratories Ltd is currently trading at Rs. 3072.35, up by Rs. 43.75 or 1.44% from its previous closing of Rs. 3028.6 on the BSE. 

Dr Reddys Laboratories Ltd has informed BSE regarding this Public Announcement ("Public Announcement") is made in relation to the Buyback of equity shares by Dr. Reddy's Laboratories Limited (the "Company") from the BSE Limited ("BSE") and the National Stock Exchange of India Limited ("NSE" and together with the BSE, the "Stock Exchanges"), pursuant to the provisions of Regulation 15(c) and 15(d) of, and in compliance with, the Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998 (including any statutory modification(s), or re-enactment for the time being in force) ("Buyback Regulations"). This Public Announcement contains disclosures as specified in Schedule II of the Buyback Regulations.

stock view:

Dr Reddys Laboratories Ltd is currently trading at Rs. 3072.35, up by Rs. 43.75 or 1.44% from its previous closing of Rs. 3028.6 on the BSE.

The scrip opened at Rs. 3079 and has touched a high and low of Rs. 3085 and Rs. 3053 respectively. So far 29563(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 51670.23 crore.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750 on 21-Jan-2016. Last one week high and low of the scrip stood at Rs. 3085 and Rs. 2974.85 respectively.

The promoters holding in the company stood at 25.57 % while Institutions and Non-Institutions held 43.5 % and 30.93 % respectively.

The stock is currently trading above its 200 DMA.

No comments:

Post a Comment